IBBA, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 2.759
AS - Asia 956
SA - Sud America 605
EU - Europa 414
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.783
Nazione #
US - Stati Uniti d'America 2.695
BR - Brasile 522
SG - Singapore 378
CN - Cina 178
VN - Vietnam 127
IT - Italia 124
HK - Hong Kong 94
DE - Germania 56
UA - Ucraina 45
AR - Argentina 41
FR - Francia 40
IN - India 34
GB - Regno Unito 31
FI - Finlandia 25
SE - Svezia 25
CA - Canada 24
TR - Turchia 24
MX - Messico 20
BD - Bangladesh 18
IQ - Iraq 15
KR - Corea 14
RU - Federazione Russa 13
ZA - Sudafrica 13
PK - Pakistan 10
PL - Polonia 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
CO - Colombia 9
EC - Ecuador 9
KE - Kenya 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
JP - Giappone 8
ID - Indonesia 7
NL - Olanda 7
VE - Venezuela 7
IL - Israele 6
MA - Marocco 6
PY - Paraguay 6
AT - Austria 5
CL - Cile 5
JO - Giordania 5
RS - Serbia 5
CR - Costa Rica 4
JM - Giamaica 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
LT - Lituania 3
NP - Nepal 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AU - Australia 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
ES - Italia 2
LB - Libano 2
LV - Lettonia 2
MU - Mauritius 2
NG - Nigeria 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CU - Cuba 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.783
Città #
Dallas 1.752
Singapore 212
San Jose 137
Chandler 119
Ashburn 108
Hong Kong 89
New York 82
Beijing 57
Ho Chi Minh City 49
Sassari 37
Los Angeles 36
Hanoi 30
Lauterbourg 30
São Paulo 28
Council Bluffs 26
Princeton 24
Rio de Janeiro 23
Shanghai 19
Belo Horizonte 18
Jacksonville 17
Ann Arbor 14
Mumbai 13
Santa Clara 13
Seoul 13
Cagliari 12
Wilmington 12
Baghdad 11
Helsinki 11
Montreal 11
Mountain View 11
Munich 11
Brasília 10
Denver 10
Warsaw 10
Barbianello 9
Buenos Aires 9
Chicago 9
Curitiba 9
Atlanta 8
Columbus 8
Falkenstein 8
Orem 8
Porto Alegre 8
Rome 8
Tashkent 8
The Dalles 8
Boardman 7
Brussels 7
Campinas 7
Johannesburg 7
Lappeenranta 7
Nairobi 7
Ribeirão Preto 7
Tokyo 7
Uberlândia 7
Bắc Ninh 6
Chennai 6
Frankfurt am Main 6
Karachi 6
Poplar 6
San Francisco 6
Toronto 6
Asunción 5
Brno 5
Brooklyn 5
Haiphong 5
London 5
Mexico City 5
Phoenix 5
Querétaro 5
Turku 5
Alvorada 4
Amman 4
Ankara 4
Barnet 4
Bogotá 4
Boston 4
Buffalo 4
Da Nang 4
Dhaka 4
Düsseldorf 4
Falls Church 4
Goiânia 4
Istanbul 4
Itaquaquecetuba 4
Kingston 4
Manchester 4
Nanchang 4
Nanjing 4
Perugia 4
Salta 4
Salvador 4
Santo André 4
Seattle 4
Secaucus 4
Stockholm 4
Volta Redonda 4
Washington 4
Abbiategrasso 3
Albissola Marina 3
Totale 3.419
Nome #
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 458
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 286
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 249
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 241
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 235
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and biological evaluation 207
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 206
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 198
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 189
Enhancement of antimicrobial activity of pump inhibitors associating drugs 184
Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based Derivatives 169
Anti-BVDV Activity Evaluation of Naphthoimidazole Derivatives Compared with Parental Imidazoquinoline Compounds 168
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 163
Antiviral activities of 5-chlorobenzotriazole derivatives 153
Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative 153
Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview 151
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 148
Antiviral activity of benzotriazole based derivatives 147
Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management 146
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 135
Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication 126
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 119
Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets 118
Dichloro-phenyl -benzotriazoles: a new selective class of human respiratory syncytial virus entry inhibitors 114
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 97
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer 94
Quinoxaline-based efflux pump inhibitors restore drug susceptibility in drug-resistant nontuberculous mycobacteria 72
Total Synthesis of the Natural Chalcone Lophirone E, Synthetic Studies toward Benzofuran and Indole-Based Analogues, and Investigation of Anti-Leishmanial Activity 68
The green chemistry of chalcones: Valuable sources of privileged core structures for drug discovery 46
Totale 4.840
Categoria #
all - tutte 15.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022120 11 0 1 8 4 4 0 12 19 16 12 33
2022/2023238 15 27 11 45 6 30 0 31 39 10 19 5
2023/2024181 9 8 8 2 31 62 4 15 0 0 27 15
2024/20251.037 3 8 43 34 16 37 96 175 312 206 55 52
2025/20263.100 114 559 1.355 322 183 93 237 35 68 100 29 5
Totale 4.840